Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
The British Journal of Dermatology
|
July 15, 2024
Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: a single-centre cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry
Angelo Li, Annelie H Musters, Ariënna Hyseni, et al.
Journal of Surgical Oncology
|
October 19, 2017
Amputations for extremity soft tissue sarcoma in an era of limb salvage treatment: Local control and survival
Marc G Stevenson, Annelie H Musters, Jan H B Geertzen, et al.
Journal of the American Academy of Dermatology
|
March 11, 2022
From the Cochrane Library: Phototherapy for atopic eczema
Katie A O'Connell, Lori S Kim, Mindy D Szeto, et al.
The Cochrane Database of Systematic Reviews
|
October 28, 2021
Phototherapy for atopic eczema
Annelie H Musters, Soudeh Mashayekhi, Jane Harvey, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 26, 2022
Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce
Angela L Bosma, Annelie H Musters, Manja Bloem, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 28, 2022
The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registry
Annelie H Musters, Conor Broderick, David Prieto-Merino, et al.
Allergy
|
March 5, 2024
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination
Anika M Valk, Jim B D Keijser, Koos P J van Dam, et al.
BMC Medicine
|
March 3, 2022
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases
Luuk Wieske, Laura Y L Kummer, Koos P J van Dam, et al.
Journal of Autoimmunity
|
January 9, 2023
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
Koos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
BMC Infectious Diseases
|
May 17, 2023
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
Koos P J van Dam, Adriaan G Volkers, Luuk Wieske, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
The British Journal of Dermatology
|
July 15, 2024
Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: a single-centre cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry
Angelo Li, Annelie H Musters, Ariënna Hyseni, et al.
Journal of Surgical Oncology
|
October 19, 2017
Amputations for extremity soft tissue sarcoma in an era of limb salvage treatment: Local control and survival
Marc G Stevenson, Annelie H Musters, Jan H B Geertzen, et al.
Journal of the American Academy of Dermatology
|
March 11, 2022
From the Cochrane Library: Phototherapy for atopic eczema
Katie A O'Connell, Lori S Kim, Mindy D Szeto, et al.
The Cochrane Database of Systematic Reviews
|
October 28, 2021
Phototherapy for atopic eczema
Annelie H Musters, Soudeh Mashayekhi, Jane Harvey, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 26, 2022
Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce
Angela L Bosma, Annelie H Musters, Manja Bloem, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 28, 2022
The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registry
Annelie H Musters, Conor Broderick, David Prieto-Merino, et al.
Allergy
|
March 5, 2024
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination
Anika M Valk, Jim B D Keijser, Koos P J van Dam, et al.
BMC Medicine
|
March 3, 2022
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases
Luuk Wieske, Laura Y L Kummer, Koos P J van Dam, et al.
Journal of Autoimmunity
|
January 9, 2023
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
Koos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
BMC Infectious Diseases
|
May 17, 2023
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
Koos P J van Dam, Adriaan G Volkers, Luuk Wieske, et al.
Page
of 2